> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Stakeholder Participation for Drug User Fee Reauthorization
- URL: https://www.fdaweb.com/stakeholder-participation-for-drug-user-fee-reauthorization/
- Published: 2020-07-09T12:00:00.000Z
- Updated: 2026-09-14T16:20:35.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147164

*Federal Register* notice: FDA is seeking patient and consumer advocacy groups, healthcare professionals, and scientific and academic experts to participate in periodic consultation meetings on reauthorizing the Prescription Drug User Fee Act (PDUFA). The user fee program expires 9/2022 and new legislation will be required for FDA to continue collecting user fees. The program requires that FDA consult with a range of stakeholders in developing recommendations for the next PDUFA program. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-07-07/pdf/2020-14585.pdf?ref=fdaweb.com).